Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines-Reference-Cited by-同舟云学术

Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines

Published:2009-02-24 Issue:2 Volume:4 Page:e4576
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gandhi Jeet,Zhang Jianling,Xie Yang,Soh Junichi,Shigematsu Hisayuki,Zhang Wei,Yamamoto Hiromasa,Peyton Michael,Girard Luc,Lockwood William W.,Lam Wan L.,Varella-Garcia Marileila,Minna John D.,Gazdar Adi F.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference54 articles.

1. Lung cancer in never smokers–a different disease.;S Sun;Nat Rev Cancer,2007

2. Cancer statistics, 2008.;A Jemal;CA Cancer J Clin,2008

3. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers.;H Shigematsu;Int J Cancer,2006

4. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors.;EK Rowinsky;Annu Rev Med,2004

5. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.;FR Hirsch;J Clin Oncol,2003

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fused in silico and bioactivity evaluation method for drug discovery: T001-10027877 was identified as an antiproliferative agent that targets EGFRT790M/C797S/L858R and EGFRT790M/L858R;BMC Chemistry;2024-08-27

2. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review;Critical Reviews in Oncology/Hematology;2024-02

3. Long non-coding RNAs in lung cancer: Unraveling the molecular modulators of MAPK signaling;Pathology - Research and Practice;2023-09

4. Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer;Pharmaceutics;2023-04-16

5. The Usefulness of Nanotechnology in Improving the Prognosis of Lung Cancer;Biomedicines;2023-02-24